Академический Документы
Профессиональный Документы
Культура Документы
3
Red Vs. Blue
4
LOOK BACK ONE
HUNDRED YEARS AND
ASK YOURSELF
How many of todays
industries were then
unknown?
5
The Answer
Automobiles
Music recording
Aviation
Internet
Healthcare
6
30 yrs ago
Only thirty
years ago
7
Now put the clock
forward twenty years
AND ASK YOURSELF
HOW MANY NOW
UNKNOWN INDUSTRIES
WILL LIKELY EXIST
THEN ?
The reality is that industries never stand still. They
continuously evolve. Operations improve, markets
expand, and players come and go.
History teaches us that we have a hugely
underestimated capacity to create new industries
and re-create existing ones.
How can a company break out of the red ocean of bloody competition?
high performance?
The Cornerstone
Value innovation
Strategy
Canvas
11
Analytical tools and
Framework
Four Action
Framework
Drop Cost
2.
structure
1
.
4.
Lift Buyer
Value/
Create New
15/01/14 Dept. Of Hospital Administration demand 12
3.
Collectively allow :
reconstruct buyer value
elements across
alternative industries to
offer buyers an entirely
new experience
while simultaneously
keeping cost structure
low.
13
Eliminate Reduce Raise
Create Grid
15
Casella Wines
CASELLA WINES CREATED YELLOW TAIL, A WINE WHOSE
STRATEGIC PROFILE BROKE FROM THE COMPETITION AND
CREATED A BLUE OCEAN.
16
Grid of Yellow Tail
Results
Instead of offering wine as wine, Casella created a social
drink accessible to everyone: beer drinkers, cock tail
drinkers, and other drinkers of non-wine beverages.
In the space of two years, the fun, social drink [yellow tail]
emerged as the fastest growing brand in the histories of both
the Australian and the U.S. wine industries and the number
one imported wine into the United States, surpassing the
wines of France and Italy.
By August 2003 it was the number one red wine in a 750-ml
bottle sold in the United States, outstripping California labels.
By mid-2003, [yellow tail]s moving average annual sales
were tracking at 4.5 million cases.
Case of Novo Nordisk
Historically, the insulin industry, like most of the
pharmaceutical industry, focused its attention on the key
influencers: doctors. The importance of doctors in affecting
the insulin purchasing decision of diabetics made doctors
the target buyer group of the industry.
Industry geared its attention and efforts to produce purer
in- sulin in response to doctors quest for better medication.
Significant challenges in administering : vials left the
patient with the complex and unpleasant task of handling
syringes & needles.
Social stigmatism for patients.
Novo Nordisk to the blue ocean opportunity of NovoPen,
launched in 1985.
The NovoPen resembled a fountain pen; it contained an insulin
cartridge.
The pen had an integrated click mechanism, making it possible
for even blind patients to control the dosing and administer
insulin.
Inject insulin with ease and convenience without the
embarrassing complexity of syringes.
Later, Innovo was designed to manage the delivery of insulin
through built-in memory and to display the dose, the last dose,
and the elapsed time.
REDUCE CREATE
Efficacy Compliance and adherence assistance
Side effects Minimization
Self Tracking Capability
Patient out of pocket minimization
Draw the SC based on:
Price
Efficacy
Side effects
Admin risk
Convenience
Self esteem
Compliance
Self Tracking
Efficacy
Side effects
Convenience
Self esteem
Nordisk
Compliance
Self track
Regular
Strategy Canvas Novo
Novo Nordisk
Visualizing Strategy
The Six Principles
The Four Organizational
Hurdles
27
The Question Remains